Pharma
Oncology vaccines: Are they positioned for PMA success?
With combinations taking center stage following the initial influx of immune checkpoint inhibitor monotherapies, the authors look ahead to the potential of mRNA vaccines in oncology and describe the pricing and market access opportunities and challenges that may await current and future...
The burden of non-specific pain disorder in US women
Based on existing evidence on the delay, lack of recognition, and burden of pain conditions commonly afflicting women (specifically endometriosis, PCOS, fibromyalgia, IBS or migraines), CRA sought to understand how being diagnosed with these conditions impacts women’s mental health and ...
The longitudinal history of medicines innovation: Part two
The second of a two-part article, CRA’s Life Sciences Practice team, along with experts at The Janssen Pharmaceutical Companies of Johnson & Johnson, recently conducted a landscape review of how complex pharmaceutical innovation happens in practice, leveraging three therapy area cas...
The longitudinal history of medicines innovation: Part One
This article is originally published in PharmaPhorum. As we move forwards in public discussions on pharmaceutical innovation and its value to patients and society, it is helpful to ground conversations in a solid understanding of how medicines development occurs. ...
State of the Art Searching Training Course
Learn when and how to perform a ‘state of the art’ patent search.
Glox Therapeutics secures £4.3M seed funding to develop precision antimicrobials targeting drug-resistant bacteria
Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria ...
Expand your horizons: think big with a Cleanroom Solutions turnkey project
Let the Guardtech Group heritage business take away the hassle of building the large-scale facility of your dreams ...
CCDC Webinar: Exploring Morphology Prediction and Handy Tips for CSD-Particle
Anticipating the physical characteristics and surface properties of a structure by analysing its chemical attributes can save significant costs and time within the pharmaceutical industry. ...
Webinar: Challenges and approaches in 3D ligand-based drug design
Discovery projects are often faced with limited protein structure information, making structure-based drug design impossible. Ligand-based methods provide a valuable alternative to allow you to identify new leads and scaffold hop, understand the physical basis of your structure-activity...
SPT Labtech launches firefly® for LDT to streamline liquid handling in NGS-based Laboratory Developed Tests
New software features and enhancements have been designed to support the rigorous and expanding needs of clinical laboratories ...